Literature DB >> 3405554

The prognostic importance of steroid receptors in endometrial carcinoma.

D C Palmer1, I M Muir, A I Alexander, M Cauchi, R C Bennett, M A Quinn.   

Abstract

Three hundred forty-nine cases of primary endometrial carcinoma (endometrioid, adenosquamous, and clear-cell) were studied to investigate the relative prognostic importance of age, menopausal status, stage, histology, myometrial invasion, and estrogen and progesterone receptor content. Excluding menopausal status, all of these variables had a significant relationship to overall survival in a univariate analysis. Using a Cox multivariate regression analysis, stage, age, and an estrogen receptor value of more than 70 fmol/mg protein, combined with a progesterone receptor value of more than 30 fmol/mg protein, were independently associated with survival. The results demonstrate that for maximum prognostic information, both estrogen and progesterone content of tumors should be measured. Maximum prognostic information is obtained by using cutoff levels that are much higher than those traditionally accepted. This has particular relevance for patient stratification in clinical trials investigating receptor information and response to adjuvant or therapeutic treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3405554

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

Review 1.  Molecular staging of gynecological cancer: What is the future?

Authors:  Pratibha S Binder; Jaime Prat; David G Mutch
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2015-03-04       Impact factor: 5.237

2.  Steroid hormone receptors and their clinical significance in cancer.

Authors:  R I Nicholson; R A McClelland; J M Gee
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

3.  Endometrial Cancer Risk Factors, Hormone Receptors, and Mortality Prediction.

Authors:  Evan L Busch; Marta Crous-Bou; Jennifer Prescott; Maxine M Chen; Michael J Downing; Bernard A Rosner; George L Mutter; Immaculata De Vivo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-04       Impact factor: 4.254

Review 4.  Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis.

Authors:  Yanli Zhang; Dong Zhao; Changguo Gong; Fengmei Zhang; Jing He; Wei Zhang; Yulan Zhao; Jing Sun
Journal:  World J Surg Oncol       Date:  2015-06-25       Impact factor: 2.754

5.  The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients.

Authors:  Soyi Lim; Yun Hwan Kim; Kwang Beom Lee; Jong Min Lee
Journal:  J Gynecol Oncol       Date:  2018-05-04       Impact factor: 4.401

6.  Integrated Bioinformatic Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Endometrial Cancer.

Authors:  Leilei Xia; Ye Wang; Qi Meng; Xiaoling Su; Jizi Shen; Jing Wang; Haiwei He; Biwei Wen; Caihong Zhang; Mingjuan Xu
Journal:  Front Oncol       Date:  2019-05-29       Impact factor: 6.244

Review 7.  Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group.

Authors:  Gian Franco Zannoni; Emma Bragantini; Francesca Castiglione; Matteo Fassan; Giancarlo Troncone; Frediano Inzani; Anna Pesci; Angela Santoro; Filippo Fraggetta
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

8.  Expression of the pNR-2/pS2 protein in diverse human epithelial tumours.

Authors:  J A Henry; M K Bennett; N H Piggott; D L Levett; F E May; B R Westley
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.